10.18632/oncotarget.4200 Oncotarget 72 WilliamsJ
But the patients most likely to benefit from it when it does arrive are the ones whove built a solid metabolic foundation now through labs, personalized GLP-1 therapy, hormone optimization, and a plan that accounts for their actual physiology rather than a generic protocol
Ultimately, Coll said, I dont think theres a silver bullet by which we can continue benefiting from the GLP-1s while completely eliminating all the GI events. He reiterated an emphasis on combination therapies with GIP and amylin to optimize tolerability
Taking ALCAR supports that brain function
Table 4 Summary of the percent correlation to markers of synaptic components and the number of spines induced by Dihexa and Nlel-AnglV treatment
The primary concern is the increased risk of aspiration , which occurs when the gastric contents rise up the esophagus (food pipe) and enter the trachea (windpipe)